Animal Health
Medical Information and Pharmacovigilance Services
Comprehensive solutions for animal heath regulatory needs
Animal Health Experience & Capabilities
24/7/365
Fully integrated, decentralized 24/7/365 contact center.
24/7/365
Fully integrated, decentralized 24/7/365 contact center.
Read LessFDA, NASC, EPA, USDA, PMRA
Experience helping clients maintain compliance with regulatory agencies.
FDA, NASC, EPA, USDA, PMRA
Experience helping clients maintain compliance with regulatory agencies.
Read LessHighly Qualified Experts
Our team includes experienced veterinarians, pharmacists, veterinary technicians, and other healthcare professionals.
Highly Qualified Experts
Our team includes experienced veterinarians, pharmacists, veterinary technicians, and other healthcare professionals.
Read LessProPharma’s Animal Health Expertise
ProPharma provides comprehensive Animal Health Medical Information (MI) and Pharmacovigilance (PV) support services, including expertise with the multiple regulatory environments that varied species and active ingredients require. ProPharma service comprises a fully integrated 24/7/365 contact center to deliver current and accurate information and improve patient health and safety as well as a team of PV experts to ensure the highest levels of compliance. ProPharma’s Animal Health team includes experienced veterinarians, pharmacists, veterinary technicians, and other healthcare professionals. This enables us to respond to medical inquiries in a manner that is not only consistent with product labeling and regulatory guidance, but also recognizes the connection between animals and people and the importance of communication between interdisciplinary healthcare professionals.
With a decentralized 24/7/365 contact center, ProPharma’s team of experts provides a customized solution to fit the medical information and pharmacovigilance needs of companies of all sizes. Whether you need to augment your internal team or need to completely outsource the Animal Health MI or PV functions globally, ProPharma has the right solution for your specific needs.
Animal Health & Toxicology Medical Information Contact Center
We offer comprehensive support around the clock. Our global 24/7/365 contact center provides crucial services, including Adverse Event (AE) intake and follow-up, Product Complaint (PC) management, and Medical Information inquiry fulfillment with escalation protocols. Our qualified MI/TOX specialists utilize market‐leading technologies to help clients deliver current and accurate information and improve patient health and safety.
We specialize in handling accidental exposure triage with thorough toxicology assessments and follow-up. Additionally, our team is adept at crisis detection and executing client emergency bullhorn actions, ensuring rapid and effective responses to urgent situations.
Our Animal Health team includes expertise with the multiple regulatory environments that varied species and active ingredients require, ensuring the highest levels of compliance. The team includes experienced veterinarians, pharmacists, veterinary technicians, and other healthcare professionals.
Animal Health Medical Writing and Content Management
Our team excels at medical writing and content management for your animal health products, leveraging our extensive expertise across various therapeutic areas and academic settings. We offer a range of services including standard document creation, custom response and content management, and response document maintenance. Additionally, our translation and localization services ensure that your critical documentation is accessible and relevant to diverse audiences.
Animal Health Pharmacovigilance Services
We ensure the highest standards of safety and compliance. Our services include comprehensive Adverse Drug Experience (ADE) assessment and processing, preparation and review of FDA Center for Veterinary Medicine (FDA CVM) ADE reports, and robust signal detection and management. We also offer seamless integration of regulatory services for non-FDA products, including but not limited to NASC, EPA/FIFRA, USDA, and Health Canada/PMRA, addressing all your pharmacovigilance needs.
Contact Us for Expert Animal Health Support
We are dedicated to enhancing the health and well-being of animals through our comprehensive Medical Information and Pharmacovigilance services. Whether you need reliable medical information, safety monitoring, or compliance support, our team of experts is here to help.
Meet Our Animal Health Experts
-
Dane Goede
Traditional Call Center Manager
View Bio
-
Karen Gjevre
Medical Information Supervisor, Traditional Call Center
View Bio
Dane Goede
Karen Gjevre
News & Insights
March 23, 2026
The Evolving Role of Functional Service Providers in Clinical Trial Medical Writ...
Discover insights from global experts and understand key industry regulations through our engaging "Meet the Expert" series and comprehensive compliance articles.
March 19, 2026
Operational Excellence in Global Clinical Research: Why Culture Drives Performan...
Discover why operational excellence in global clinical research hinges on culture, not just metrics. Learn how leadership, trust, and collaboration drive consistent quality outcomes.
January 27, 2026
ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero T...
ProPharma’s greenhouse gas reduction targets are validated by SBTi, aligning with the Net-Zero Standard and a commitment to reach net-zero by 2050.
December 11, 2025
ProPharma Expands Operations with New Office in Hyderabad
ProPharma expands with a new office in Hyderabad, enhancing innovation and growth in regulatory, clinical, and compliance services for the life sciences industry.
January 31, 2025
ProPharma Recognized for AI Excellence at ECCCSA
ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.
October 9, 2024
ProPharma Receives 2024 CPHI Regulatory and Compliance Award
ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.
March 23, 2026
Real World Evidence for Class III Devices: A Smarter Path to PMA
Struggling to generate clinical evidence for Class III devices without costly, multi-year trials? Discover how ProPharma helped an orthopedic device company leverage existing registry data to support...
March 16, 2026
CMO Compass & Supply Chain Management
ProPharma provides comprehensive supply chain management and consulting services to support the efficient delivery of clinical trial materials throughout the product lifecycle. Using its CMO Compass®...
March 13, 2026
Restoring Inspection Readiness and Building a Long-Term Pharmacovigilance Partne...
A mid-sized biotechnology company operating in the EU faced critical pharmacovigilance (PV) compliance findings following an inspection by the European Medicines Agency and Medicines and Healthcare...
April 23, 2026
Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market
As cell and gene therapies transition from clinical development to commercialization, organizations face evolving regulatory expectations, expanded CMC requirements, and increased MAH...
April 9, 2026
EMA Policy 0070: Advanced Strategies for Compliance, Anonymization, and CCI Justification
As European Medicines Agency Policy 0070 enters its expanded Step 2 phase, sponsors face increased document volumes, heightened transparency obligations, and greater scrutiny of anonymization and CCI...
News & Insights
March 13, 2026
Restoring Inspection Readiness and Building a Long-Term Pharmacovigilance Partne...
A mid-sized biotechnology company operating in the EU faced critical pharmacovigilance (PV) compliance findings following an inspection by the European Medicines Agency and Medicines and Healthcare...
April 9, 2026
EMA Policy 0070: Advanced Strategies for Compliance, Anonymization, and CCI Justification
As European Medicines Agency Policy 0070 enters its expanded Step 2 phase, sponsors face increased document volumes, heightened transparency obligations, and greater scrutiny of anonymization and CCI...